Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women

Cairo University (CU)

Status: Enrolling

Conditions: Cardiovascular Complication

Treatments: Other: Progressive muscle relaxation; Dietary Supplement: DASH diet; Drug: Anti hypertensive drugs

Study type: Interventional

Funder types: Other

Identifiers

NCT06600347

P.T.REC/012/004059

Details and patient eligibility

About

This study will be conducted to investigate the effect of DASH diet and Progressive muscle relaxation on cardiovascular risks in postmenopausal women.

Full description

Cardiovascular disease is the leading cause of morbidity and mortality in men and women, but the incidence of cardiovascular disease related deaths is higher in women than men. Hypertension is one of the leading risk factors for cardiovascular disease. Aging in both men and women is characterized by increases in blood pressure (BP), but the age-related increases are more rapid in women particularly postmenopausal women than in men.

A variety of non-pharmacologic treatments to manage stress have been found effective in reducing blood pressure and the development of hypertension. The DASH eating pattern promotes blood pressure reduction by encouraging the consumption of foods that are low in saturated fat, total fat, cholesterol, and sodium and high in potassium, calcium, magnesium, fiber, and protein. In terms of actual food choices, the DASH eating pattern encourages whole grains, fat free or low-fat dairy products, fruits, vegetables, poultry, fish, and nuts. Foods that are limited include fatty meats, full-fat dairy products, tropical oils (e.g., coconut, palm, and palm kernel oils), and sweets and sugar sweetened beverages.

The mechanism by which relaxation techniques lower blood pressure is unclear. One theory suggests that they may help lower the stress and physiologic arousal produced by the autonomic nervous system, thereby reducing blood pressure. So this study is a trial to determine the effect of DASH diet and progressive muscle relaxation in reducing cardiovascular risks in postmenopausal women.

Enrollment: 90 estimated patients

Sex: Female

Ages: 50 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The participant's ages will be ranged from 50- 60 years old.
• Their body mass index will be ranged from 30-35 kg/m2.
• All women are hypertensive at least one year postmenopause.
• Their scores in perceived stress scale will be ranged from 14-40.

Exclusion criteria

• Women with systolic blood pressure (SBP) >160 mmHg or diastolic blood pressure (DBP) >100mmHg.
• Women who have other known causes of hypertension, such as renal diseases.
• Women who are using sedatives or tranquilizer or antidepressant drugs.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

90 participants in 3 patient groups

DASH diet group

Experimental group

Description:

The participants will be treated with the DASH diet and antihypertensive drugs

Treatment:

Drug: Anti hypertensive drugs

Dietary Supplement: DASH diet

Progressive muscle relaxation group

Experimental group

Description:

The participants will be treated with progressive muscle relaxation and antihypertensive drugs

Treatment:

Drug: Anti hypertensive drugs

Other: Progressive muscle relaxation

DASH diet and progressive muscle relaxation group

Experimental group

Description:

The participants will be treated with DASH diet and progressive muscle relaxation in addition to antihypertensive drugs

Treatment:

Drug: Anti hypertensive drugs

Dietary Supplement: DASH diet

Other: Progressive muscle relaxation